To define the mechanism(s) responsible for the negative inotropic effects of tumor necrosis factor-alpha (TNF alpha) in the adult heart, we examined the functional effects of TNF alpha in the intact left ventricle and the isolated adult cardiac myocyte. Studies in both the ventricle and the isolated adult cardiac myocyte showed that TNF alpha exerted a concentration- and time-dependent negative inotropic effect that was fully reversible upon removal of this cytokine. Further, treatment with a neutralizing anti-TNF alpha antibody prevented the negative inotropic effects of TNF alpha in isolated myocytes. A cellular basis for the above findings was provided by studies which showed that treatment with TNF alpha resulted in decreased levels of peak intracellular calcium during the systolic contraction sequence; moreover, these findings did not appear to be secondary to alterations in the electrophysiological properties of the cardiac myocyte. Further studies showed that increased levels of nitric oxide, de novo protein synthesis, and metabolites of the arachidonic acid pathway were unlikely to be responsible for the TNF alpha-induced abnormalities in contractile function. Thus, these studies constitute the initial demonstration that the negative inotropic effects of TNF alpha are the direct result of alterations in intracellular calcium homeostasis in the adult cardiac myocyte.
T Yokoyama, L Vaca, R D Rossen, W Durante, P Hazarika, D L Mann
Title and authors | Publication | Year |
---|---|---|
The molecular mechanisms associated with the physiological responses to inflammation and oxidative stress in cardiovascular diseases
S Zhazykbayeva, S Pabel, A Mügge, S Sossalla, N Hamdani |
Biophysical Reviews | 2020 |
Minocycline reverses IL-17A/TRAF3IP2-mediated p38 MAPK/NF-κB/iNOS/NO-dependent cardiomyocyte contractile depression and death
T Yoshida, NA Das, AJ Carpenter, R Izadpanah, SA Kumar, S Gautam, SB Bender, U Siebenlist, B Chandrasekar |
Cellular Signalling | 2020 |
Inflammation in Heart Failure
SP Murphy, R Kakkar, CP McCarthy, JL Januzzi |
Journal of the American College of Cardiology | 2020 |
The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction
A Hammer, P Sulzgruber, L Koller, N Kazem, F Hofer, B Richter, S Blum, M Hülsmann, J Wojta, A Niessner |
Mediators of Inflammation | 2020 |
Reappraising the role of inflammation in heart failure
L Adamo, C Rocha-Resende, SD Prabhu, DL Mann |
Nature Reviews Cardiology | 2020 |
The Dynamic Interplay Between Cardiac Inflammation and Fibrosis
TP Thomas, LA Grisanti |
Frontiers in physiology | 2020 |
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
A Hanna, NG Frangogiannis |
Cardiovascular Drugs and Therapy | 2020 |
Cirrhotic Cardiomyopathy
KT Yoon, H Liu, SS Lee |
Current Gastroenterology Reports | 2020 |
Non-thyroidal illness syndrome, the hidden player in the septic shock induced myocardial contractile depression
J Lado-Abeal |
Medical Hypotheses | 2020 |
A potential role of caspase recruitment domain family member 9 (Card9) in transverse aortic constriction-induced cardiac dysfunction, fibrosis, and hypertrophy
MR Peterson, Y Getiye, L Bosch, AJ Sanders, AR Smith, S Haller, K Wilson, DP Thomas, G He |
Hypertension Research | 2020 |
SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19
M Briguglio, M Porta, F Zuffada, AR Bona, T Crespi, F Pino, P Perazzo, M Mazzocchi, R Giorgino, GD Angelis, A Ielasi, GD Blasio, M Turiel |
Frontiers in physiology | 2020 |
Vitamin D, cardio-inflammation, and endothelial dysfunction in older adults after orthopedic surgery: Results from an open-label trial to ameliorate cardiac function
M Briguglio, G Lombardi, V Sansoni, S Perego, VD Colonna, D Stella, C Colombo, M Bonadies, GD Blasio, G Banfi, M Turiel |
Nutrition Clinique et Métabolisme | 2020 |